219 related articles for article (PubMed ID: 20425409)
1. Prognostic factors in low-grade non-Hodgkin lymphomas.
Federico M; Molica S; Bellei M; Luminari S
Curr Hematol Malig Rep; 2009 Oct; 4(4):202-10. PubMed ID: 20425409
[TBL] [Abstract][Full Text] [Related]
2. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
3. The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas.
Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
Ann Intern Med; 1988 Dec; 109(12):939-45. PubMed ID: 3057985
[TBL] [Abstract][Full Text] [Related]
4. Prognostic assessment in patients with indolent B-cell lymphomas.
Arcaini L; Rattotti S; Gotti M; Luminari S
ScientificWorldJournal; 2012; 2012():107892. PubMed ID: 22919288
[TBL] [Abstract][Full Text] [Related]
5. Classification of primary gastric lymphomas according to histologic features.
Hsi ED; Eisbruch A; Greenson JK; Singleton TP; Ross CW; Schnitzer B
Am J Surg Pathol; 1998 Jan; 22(1):17-27. PubMed ID: 9422312
[TBL] [Abstract][Full Text] [Related]
6. Ocular adnexal lymphomas: five case presentations and a review of the literature.
Coupland SE; Hummel M; Stein H
Surv Ophthalmol; 2002; 47(5):470-90. PubMed ID: 12431695
[TBL] [Abstract][Full Text] [Related]
7. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
[TBL] [Abstract][Full Text] [Related]
8. Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas.
Nicotra G; Mercalli F; Peracchio C; Castino R; Follo C; Valente G; Isidoro C
Mod Pathol; 2010 Jul; 23(7):937-50. PubMed ID: 20473282
[TBL] [Abstract][Full Text] [Related]
9. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.
Raible MD; Hsi ED; Alkan S
Am J Clin Pathol; 1999 Jul; 112(1):101-7. PubMed ID: 10396291
[TBL] [Abstract][Full Text] [Related]
10. Eleven-year experience of low grade lymphoma in Korea (based on REAL classification).
Hahn JS; Kim YS; Lee YC; Yang WI; Lee SY; Suh CO
Yonsei Med J; 2003 Oct; 44(5):757-70. PubMed ID: 14584090
[TBL] [Abstract][Full Text] [Related]
11. Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.
Cabanillas F; Rivera N; Pardo WI
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):550-557. PubMed ID: 27618361
[TBL] [Abstract][Full Text] [Related]
12. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.
Møller MB; Nielsen O; Pedersen NT
Mod Pathol; 1999 Nov; 12(11):1010-6. PubMed ID: 10574597
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors in Hodgkin and non-Hodgkin lymphomas].
Cuenca X; Xhaard A; Mounier N
Bull Cancer; 2009 Apr; 96(4):461-73. PubMed ID: 19357020
[TBL] [Abstract][Full Text] [Related]
14. Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival.
Medeiros LJ; Picker LJ; Horning SJ; Warnke RA
Cancer; 1988 May; 61(9):1844-51. PubMed ID: 3355978
[TBL] [Abstract][Full Text] [Related]
15. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
[TBL] [Abstract][Full Text] [Related]
16. Management of histologically indolent non-Hodgkin's lymphomas.
Solal-Celigny P
Baillieres Clin Haematol; 1996 Dec; 9(4):669-87. PubMed ID: 9138612
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas.
Coiffier B
Curr Opin Oncol; 1991 Oct; 3(5):843-51. PubMed ID: 1751578
[TBL] [Abstract][Full Text] [Related]
19. Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.
Fowler NH; Davis RE; Rawal S; Nastoupil L; Hagemeister FB; McLaughlin P; Kwak LW; Romaguera JE; Fanale MA; Fayad LE; Westin JR; Shah J; Orlowski RZ; Wang M; Turturro F; Oki Y; Claret LC; Feng L; Baladandayuthapani V; Muzzafar T; Tsai KY; Samaniego F; Neelapu SS
Lancet Oncol; 2014 Nov; 15(12):1311-8. PubMed ID: 25439689
[TBL] [Abstract][Full Text] [Related]
20. A clinico-pathological and prognostic analysis of non-Hodgkin lymphoma. A study of 203 patients.
Nabholtz JM; Friedman S; Bastien H; Cuisenier J; Horiot JC; Guerrin J
Acta Oncol; 1988; 27(5):489-95. PubMed ID: 3203007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
